Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)

2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)

pharmaceutical raw materials
2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1) structure

2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1) 

structure
  • CAS No:

    155141-29-0

  • Formula:

    C18H19N3O3S.C4H4O4

  • Chemical Name:

    2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)

  • Synonyms:

    2,4-Thiazolidinedione,5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-,(2Z)-2-butenedioate (1:1);2,4-Thiazolidinedione,5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-,(Z)-2-butenedioate (1:1);BRL 49653C;Rosiglitazone maleate;Avandia;5-[[4-[2-(N-Methyl-N-2-pyridylamino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione maleate

  • Categories:

    Active Pharmaceutical Ingredients  >  Antibiotics

Description

White To Off-White SolidRosiglitazone maleate, belongs to a novel class of thiazolidine diones launched for the treatment of non-insulin-dependent diabetes mellitus (NIDDM), a disease characterized by a pancreatic β-cell defect and insulin resistance in the liver and peripheral tissues. The racemic base can be obtained by KnSvenagel condensation between 2, 4-thiazolidinedione and the corresponding 4-substituted benzaldehyde (itself prepared in 2 steps from 2-chloropyridine), followed by r

2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1) Basic Attributes

473.5

473.126

1312995-182-4

2933990090

Characteristics

171

3.24950

off-white solid

1.4±0.1 g/cm3

235-240°C

585°C at 760 mmHg

307.6ºC

1.688

68.2 [ug/mL]

-20°C Freezer

Safety Information

3

20/21/22-36/38

24/25-37/39-26

Xi

P201, P202, P261, P264, P270, P271, P273, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P330, P332+P313, P337+P313, P362, P391, P403+P233, P405, P501

H302

2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1) Use and Manufacturing

Thiazolidinediones (TZDs) are a group of structurally related peroxisome proliferator-activated receptor γ (PPARγ) agonists with antidiabetic actions in vivo. Rosiglitazone is a prototypical TZD that has served as a reference compound for this class. It is a potent and selective PPARγ ligand that binds to the PPARγ ligand-binding domain with a Kd value of 43 nM. It activates luciferase-based expression constructs PPARγ1 and PPARγ2 with EC50 values of approximately 30 nM and 100 nM, respectively. Rosiglitazone is active in vivo as an antidiabetic agent in the ob/ob mouse model, and has been used as an oral hypoglycemic agent in the treatment of type 2 diabetes in humans for many years.[Cayman Chemical]

Drug Function and Efficacy

The oral absorption bioavailability of this product is 99%, the plasma peak time is about 1 hour, and the plasma elimination half-life (t1/2) is 3 to 4 hours. Eating has no significant effect on the total absorption of this product, but the peak time is delayed by 2.2 hours and the peak value is reduced by 20%. The average oral distribution volume of this product is 17.6L (30%). 99.8% is bound to plasma proteins, mainly albumin. It is mainly excreted from the urine in its original form, and the main metabolic pathway is to bind to sulfate or glucuronic acid through N-demethylation and hydroxylation. All circulating metabolites have no insulin sensitizing effect. In vitro tests have confirmed that most of this product is metabolized through the CYP2C8 pathway of the P450 enzyme system, and a small amount is metabolized through the CYP2C9 pathway. After oral or intravenous administration of 14C-labeled rosiglitazone, 64% is excreted through urine and 23% is excreted through feces. Clinical studies have confirmed that the pharmacokinetic parameters of rosiglitazone are not affected by age, race, smoking or drinking.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

Recommended Suppliers of 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.